Understanding how a protein helps HIV and COVID-19 viruses assemble

Determining the role of AnnexinA2 in HIV-1 and SARS-CoV-2 assembly

NIH-funded research California State University Long Beach · NIH-10937390

This study is looking at how a protein called AnnexinA2 helps the HIV and COVID-19 viruses to infect cells better, with the hope that understanding this process will lead to new treatments for these infections.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionCalifornia State University Long Beach NIH-funded
Lab location1 site (Long Beach, United States)
Project IDNIH-10937390 on NIH RePORTER

What this research studies

This research investigates the role of a protein called AnnexinA2 in the assembly of HIV-1 and SARS-CoV-2 viruses. By studying how these viruses use lipid rafts—specialized areas in cell membranes—to enhance their infection capabilities, the research aims to uncover the mechanisms that allow these viruses to thrive. The approach involves examining the interaction between AnnexinA2 and viral proteins, which could lead to new therapeutic strategies to combat these infections. Patients may benefit from insights gained that could inform the development of antiviral therapies targeting these mechanisms.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals affected by HIV-1 or COVID-19, particularly those who may benefit from novel antiviral therapies.

Not a fit: Patients who are not infected with HIV-1 or SARS-CoV-2 may not receive direct benefits from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that effectively reduce the impact of HIV and COVID-19 infections.

How similar studies have performed: Previous research has shown that targeting viral assembly mechanisms can be effective, suggesting potential success for this approach.

Where this research is happening

Long Beach, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Acquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome Virus
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.